{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:37:49Z","timestamp":1788435469599,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12325-025-03217-4","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:33:44Z","timestamp":1748504024000},"page":"3455-3471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prurigo Nodularis PaTient-Reported BurdEn of SicKness (PN TREK): A Cross-Sectional Survey of Patient-Reported Burden of Disease in Patients with PN from the US"],"prefix":"10.1007","volume":"42","author":[{"given":"Shawn G.","family":"Kwatra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Zion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengisu","family":"Ozarslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donia","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Payan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-2073","authenticated-orcid":false,"given":"Ryan B.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"3","key":"3217_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamadermatol.2021.5307","volume":"158","author":"SG Kwatra","year":"2022","unstructured":"Kwatra SG. Prurigo Nodularis. JAMA Dermatol. 2022;158(3):336. https:\/\/doi.org\/10.1001\/jamadermatol.2021.5307.","journal-title":"JAMA Dermatol"},{"key":"3217_CR2","doi-asserted-by":"publisher","first-page":"1022889","DOI":"10.3389\/fmed.2022.1022889","volume":"9","author":"J Deng","year":"2022","unstructured":"Deng J, Parthasarathy V, Marani M, Bordeaux Z, Lee K, Trinh C, et al. Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis. Front Med (Lausanne). 2022;9:1022889. https:\/\/doi.org\/10.3389\/fmed.2022.1022889.","journal-title":"Front Med (Lausanne)"},{"key":"3217_CR3","doi-asserted-by":"publisher","first-page":"1011142","DOI":"10.3389\/fmed.2022.1011142","volume":"9","author":"V Parthasarathy","year":"2022","unstructured":"Parthasarathy V, Cravero K, Deng J, Sun Z, Engle SM, Auxier AN, et al. Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: a cluster analysis. Front Med (Lausanne). 2022;9:1011142. https:\/\/doi.org\/10.3389\/fmed.2022.1011142.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"3217_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jid.2019.07.697","volume":"140","author":"AH Huang","year":"2020","unstructured":"Huang AH, Canner JK, Khanna R, Kang S, Kwatra SG. Real-world prevalence of Prurigo Nodularis and burden of associated diseases. J Invest Dermatol. 2020;140(2):480-483.e4. https:\/\/doi.org\/10.1016\/j.jid.2019.07.697.","journal-title":"J Invest Dermatol"},{"key":"3217_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jdin.2020.10.009","volume":"2","author":"S St\u00e4nder","year":"2021","unstructured":"St\u00e4nder S, Augustin M, Berger T, Elmariah S, Korman NJ, Weisshaar E, et al. Prevalence of prurigo nodularis in the United States of America: a retrospective database analysis. JAAD Int. 2021;2:28\u201330. https:\/\/doi.org\/10.1016\/j.jdin.2020.10.009.","journal-title":"JAAD Int"},{"issue":"18","key":"3217_CR6","doi-asserted-by":"publisher","first-page":"adv00309","DOI":"10.2340\/00015555-3655","volume":"100","author":"S St\u00e4nder","year":"2020","unstructured":"St\u00e4nder S, Ketz M, Kossack N, Akumo D, Pignot M, Gabriel S, et al. Epidemiology of Prurigo Nodularis compared with psoriasis in Germany: a claims database analysis. Acta Derm Venereol. 2020;100(18):adv00309. https:\/\/doi.org\/10.2340\/00015555-3655.","journal-title":"Acta Derm Venereol."},{"issue":"6","key":"3217_CR7","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"SA-O Barbarot","year":"2018","unstructured":"Barbarot SA-O, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284\u201393. https:\/\/doi.org\/10.1111\/all.13401.","journal-title":"Allergy."},{"issue":"3","key":"3217_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2018.04.044","volume":"79","author":"S Steinke","year":"2018","unstructured":"Steinke S, Zeidler C, Riepe C, Bruland P, Soto-Rey I, Storck M, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol. 2018;79(3):457-463.e5. https:\/\/doi.org\/10.1016\/j.jaad.2018.04.044.","journal-title":"J Am Acad Dermatol"},{"key":"3217_CR9","doi-asserted-by":"publisher","first-page":"00403","DOI":"10.2340\/00015555-3726","volume":"101","author":"MP Pereira","year":"2021","unstructured":"Pereira MP, Zeidler C, Wallengren J, Halvorsen JA, Weisshaar E, Garcovich S, Misery L, et al. Chronic Nodular Prurigo: a European cross-sectional study of patient perspectives on therapeutic goals and satisfaction. Acta Derm Venereol. 2021;101:00403. https:\/\/doi.org\/10.2340\/00015555-3726.","journal-title":"Acta Derm Venereol."},{"issue":"4","key":"3217_CR10","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jaad.2018.04.047","volume":"79","author":"E Boozalis","year":"2018","unstructured":"Boozalis E, Tang O, Patel S, Semenov YR, Pereira MP, St\u00e4nder S, et al. Ethnic differences and comorbidities of 909 prurigo nodularis patients. J Am Acad Dermatol. 2018;79(4):714-719.e3. https:\/\/doi.org\/10.1016\/j.jaad.2018.04.047.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3217_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/jcm11010095","volume":"11","author":"Y-R Woo","year":"2022","unstructured":"Woo Y-R, Wang S, Sohn K-A, Kim H-S. Epidemiology, comorbidities, and prescription patterns of Korean prurigo nodularis patients: a multi-institution study. J Clin Med. 2022;11(1):95. https:\/\/doi.org\/10.3390\/jcm11010095.","journal-title":"J Clin Med"},{"issue":"2","key":"3217_CR12","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1111\/jdv.13827","volume":"31","author":"KM J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen KM, Egeberg A, Gislason GH, Skov L, Thyssen JP. Anxiety, depression and suicide in patients with prurigo nodularis. J Eur Acad Dermatol Venereol. 2017;31(2):e106\u20137. https:\/\/doi.org\/10.1111\/jdv.13827.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"3217_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/1346-8138.17045","volume":"51","author":"H Murota","year":"2024","unstructured":"Murota H, Arima K, Yoshida T, Fujita H. Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan. J Dermatol. 2024;51(3):223\u201333. https:\/\/doi.org\/10.1111\/1346-8138.17045.","journal-title":"J Dermatol"},{"issue":"5","key":"3217_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s40257-018-0381-6","volume":"19","author":"JI Silverberg","year":"2018","unstructured":"Silverberg JI, Kantor RW, Dalal P, Hickey C, Shaunfield S, Kaiser K, et al. A comprehensive conceptual model of the experience of chronic itch in adults. Am J Clin Dermatol. 2018;19(5):759\u201369. https:\/\/doi.org\/10.1007\/s40257-018-0381-6.","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"3217_CR15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41591-023-02320-9","volume":"29","author":"G Yosipovitch","year":"2023","unstructured":"Yosipovitch G, Mollanazar N, St\u00e4nder S, Kwatra SG, Kim BS, Laws E, et al. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. Nat Med. 2023;29(5):1180\u201390. https:\/\/doi.org\/10.1038\/s41591-023-02320-9.","journal-title":"Nat Med"},{"key":"3217_CR16","unstructured":"Available from: http:\/\/www.pruritussymposium.de\/numericalratingscale.html. Accessed 2023."},{"issue":"3","key":"3217_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2133.2009.09586.x","volume":"162","author":"S Elman","year":"2010","unstructured":"Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587\u201393. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09586.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"3217_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12882-017-0475-z","volume":"18","author":"JW Lai","year":"2017","unstructured":"Lai JW, Chen HC, Chou CY, Yen HR, Li TC, Sun MF, et al. Transformation of 5-D itch scale and numerical rating scale in chronic hemodialysis patients. BMC Nephrol. 2017;18(1):56. https:\/\/doi.org\/10.1186\/s12882-017-0475-z.","journal-title":"BMC Nephrol"},{"issue":"2","key":"3217_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69\u201377. https:\/\/doi.org\/10.1016\/S0022-3999(01)00296-3.","journal-title":"J Psychosom Res"},{"issue":"6","key":"3217_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.jaad.2020.04.183","volume":"83","author":"AH Huang","year":"2020","unstructured":"Huang AH, Williams KA, Kwatra SG. Prurigo nodularis: epidemiology and clinical features. J Am Acad Dermatol. 2020;83(6):1559\u201365. https:\/\/doi.org\/10.1016\/j.jaad.2020.04.183.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"3217_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/ced.14722","volume":"46","author":"P Aggarwal","year":"2021","unstructured":"Aggarwal P, Choi J, Sutaria N, Roh YS, Wongvibulsin S, Williams KA, et al. Clinical characteristics and disease burden in prurigo nodularis. Clin Exp Dermatol. 2021;46(7):1277\u201384. https:\/\/doi.org\/10.1111\/ced.14722.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"3217_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-4362.2002.01436.x","volume":"41","author":"G Kiebert","year":"2002","unstructured":"Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol. 2002;41(3):151\u20138. https:\/\/doi.org\/10.1046\/j.1365-4362.2002.01436.x.","journal-title":"Int J Dermatol"},{"issue":"6","key":"3217_CR23","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2165\/00019053-199610060-00010","volume":"10","author":"MB Nichol","year":"1996","unstructured":"Nichol MB, Margolies JE, Lippa E, Rowe M, Quell J. The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis. Pharmacoeconomics. 1996;10(6):644\u201353. https:\/\/doi.org\/10.2165\/00019053-199610060-00010.","journal-title":"Pharmacoeconomics"},{"key":"3217_CR24","doi-asserted-by":"publisher","first-page":"adv00823","DOI":"10.2340\/actadv.v103.4426","volume":"103","author":"E Weisshaar","year":"2023","unstructured":"Weisshaar E, Bentz P, Apfelbacher C, Haufe E, Heinrich L, Heratizadeh A, et al. Itching in atopic dermatitis: patient- and physician-reported outcomes in the German atopic dermatitis registry TREATgermany. Acta Derm Venereol. 2023;103:adv00823. https:\/\/doi.org\/10.2340\/actadv.v103.4426.","journal-title":"Acta Derm Venereol."},{"issue":"4","key":"3217_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/bjd.18296","volume":"182","author":"L Andersen","year":"2020","unstructured":"Andersen L, Nyeland ME, Nyberg F. Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A. Br J Dermatol. 2020;182(4):1007\u201316. https:\/\/doi.org\/10.1111\/bjd.18296.","journal-title":"Br J Dermatol."},{"issue":"2","key":"3217_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/itx.0000000000000061","volume":"7","author":"C Zeidler","year":"2022","unstructured":"Zeidler C, Pereira MP, Storck M, Suer A, St\u00e4nder S. Severity stages of chronic nodular prurigo: analysis of associated itch intensity and quality of life impairment. Itch (Phila). 2022;7(2): e61. https:\/\/doi.org\/10.1097\/itx.0000000000000061.","journal-title":"Itch (Phila)"},{"issue":"4","key":"3217_CR27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1185\/03007990902774765","volume":"25","author":"DE Stull","year":"2009","unstructured":"Stull DE, Leidy NK, Parasuraman B, Chassany O. Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin. 2009;25(4):929\u201342. https:\/\/doi.org\/10.1185\/03007990902774765.","journal-title":"Curr Med Res Opin"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03217-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03217-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03217-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T08:14:39Z","timestamp":1750493679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03217-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3217"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03217-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Shawn G Kwatra\u2014AbbVie, Arcutis Biotherapeutics, Aslan Pharmaceuticals, Celldex Therapeutics, Galderma, Genzada Pharmaceuticals, Incyte, Johnson & Johnson, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., Sanofi\u2014advisory board member\/consultant; Galderma, Incyte, Pfizer, Sanofi\u2014investigator. Min Yang, Bruno Martins, Abigail Zion, and Jingyi Liu\u2014employees of Analysis Group and may hold stocks and\/or stock options in the company; Joseph Zahn, and Ryan B Thomas\u2014employees of Regeneron Pharmaceuticals Inc. and may hold stocks and\/or stock options in the company; Bengisu Ozarslan, Donia Bahloul, Marine Payan\u2014employees of Sanofi and may hold stocks and\/or stock options in the company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The study was exempted from needing ethical approval by the Pearl Local Ethics Committee (according to FDA 21 CFR 56.104 and 45 CFR46.104(b)(2): (2) Tests, Surveys, Interviews). Informed consent to participate and consent for publication were obtained from all participants before study enrolment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}